Epitopes that included amino acid residues at 31–33, which are absent in the B.1.1.529 variant, exhibited low-intensity binding of Abs but stimulated IFNγ release in COVID-19 convalescents [26,44]. The gene discussed is DDX41; the disease is COVID-19.